Citizens in Canada and Europe have one clear option: reject CETA before it is ratified. If ratified, CETA will unfairly restrict how local governments source and procure goods and services, add hundreds of millions of dollars to the price of pharmaceutical drugs in our public health care system, create pressure to increase privatization of local water systems, transit and energy, and give...
Also inside: Avi Lewis: Why we should all leap | The human experience of the Husky Oil spill | Boiling Point: Government Neglect, Corporate Abuse and Canada’s Water Crisis
Universal pharmacare should be a core part of the next Health Accord. This report comes as the federal, provincial and territorial health ministers are meeting today to negotiate a new Canada Health Accord
In this report, Savaria Expert-Conseils Inc. evaluates the impacts of a petroleum hydrocarbons spill from TransCanada’s Energy East pipeline in the main watercourses of the Ottawa-Gatineau region.
Print version of the Nestle Boycott Declaration.
Take the online pledge here.
The Blue Communities Project was created to help community activists and local leaders protect the water commons – our shared water resources and services. As a public sector worker, elected official or community activist pursuing the recognition of a “Blue Community,” you will become part of a growing international movement for public water.
Canada’s experience with food regulations under the North American Free Trade Agreement (NAFTA) shows that the threats trade agreements pose to food quality and safety are very real in free trade agreements.
This is an update of a December 2015 review by Dr. Ken Froese of TransCanada’s Human Health Risk Assessment since the company announced it was doubling the size of its tank farm in Saint John and updated its assessment. Gaps remain.
Dr. Froese identifies three key environmental health issues:
The Trans-Pacific Partnership (TPP) is bad medicine. This trade deal, which was recently signed by Canada, the United States, Mexico and nine other Pacific Rim countries, will keep the costs of prescription medications high, undermine the ability to draft quality public health care policy, and make it more difficult to create a national pharmacare program.